Table of Contents

1 Study Coverage

• 1.1 Intrauterine Devices Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Intrauterine Devices Market Size Growth Rate by Product
  • 1.4.2 Hormonal IUD
  • 1.4.3 Copper IUD
• 1.5 Market by End User
  • 1.5.1 Global Intrauterine Devices Market Size Growth Rate by End User
  • 1.5.2 Age 20-24
  • 1.5.3 Age 25-34
  • 1.5.4 Age 35-44
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Intrauterine Devices Market Size
  • 2.1.1 Global Intrauterine Devices Revenue 2014-2025
  • 2.1.2 Global Intrauterine Devices Sales 2014-2025
• 2.2 Intrauterine Devices Growth Rate by Regions
  • 2.2.1 Global Intrauterine Devices Sales by Regions
  • 2.2.2 Global Intrauterine Devices Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Intrauterine Devices Sales by Manufacturers
  • 3.1.1 Intrauterine Devices Sales by Manufacturers
  • 3.1.2 Intrauterine Devices Sales Market Share by Manufacturers
  • 3.1.3 Global Intrauterine Devices Market Concentration Ratio (CR5 and HHI)
• 3.2 Intrauterine Devices Revenue by Manufacturers
  • 3.2.1 Intrauterine Devices Revenue by Manufacturers (2014-2019)
  • 3.2.2 Intrauterine Devices Revenue Share by Manufacturers (2014-2019)
• 3.3 Intrauterine Devices Price by Manufacturers
• 3.4 Intrauterine Devices Manufacturing Base Distribution, Product Types
  • 3.4.1 Intrauterine Devices Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Intrauterine Devices Product Type
  • 3.4.3 Date of International Manufacturers Enter into Intrauterine Devices Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Intrauterine Devices Sales by Product
• 4.2 Global Intrauterine Devices Revenue by Product
• 4.3 Intrauterine Devices Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Intrauterine Devices Breakdown Data by End User

6 North America

• 6.1 North America Intrauterine Devices by Countries
  • 6.1.1 North America Intrauterine Devices Sales by Countries
  • 6.1.2 North America Intrauterine Devices Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Intrauterine Devices by Product
• 6.3 North America Intrauterine Devices by End User

7 Europe

• 7.1 Europe Intrauterine Devices by Countries
  • 7.1.1 Europe Intrauterine Devices Sales by Countries
  • 7.1.2 Europe Intrauterine Devices Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Intrauterine Devices by Product
• 7.3 Europe Intrauterine Devices by End User

8 Asia Pacific

• 8.1 Asia Pacific Intrauterine Devices by Countries
  • 8.1.1 Asia Pacific Intrauterine Devices Sales by Countries
  • 8.1.2 Asia Pacific Intrauterine Devices Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Intrauterine Devices by Product
• 8.3 Asia Pacific Intrauterine Devices by End User

9 Central & South America

• 9.1 Central & South America Intrauterine Devices by Countries
  • 9.1.1 Central & South America Intrauterine Devices Sales by Countries
  • 9.1.2 Central & South America Intrauterine Devices Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Intrauterine Devices by Product
• 9.3 Central & South America Intrauterine Devices by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Intrauterine Devices by Countries
  • 10.1.1 Middle East and Africa Intrauterine Devices Sales by Countries
  • 10.1.2 Middle East and Africa Intrauterine Devices Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Intrauterine Devices by Product
• 10.3 Middle East and Africa Intrauterine Devices by End User

11 Company Profiles

• 11.1 Bayer
  • 11.1.1 Bayer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Bayer Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Bayer Intrauterine Devices Products Offered
  • 11.1.5 Bayer Recent Development
• 11.2 Merck
  • 11.2.1 Merck Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Merck Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Merck Intrauterine Devices Products Offered
  • 11.2.5 Merck Recent Development
• 11.3 Teva Pharmaceutical
  • 11.3.1 Teva Pharmaceutical Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Teva Pharmaceutical Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Teva Pharmaceutical Intrauterine Devices Products Offered
  • 11.3.5 Teva Pharmaceutical Recent Development
• 11.4 Allergan
  • 11.4.1 Allergan Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Allergan Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Allergan Intrauterine Devices Products Offered
  • 11.4.5 Allergan Recent Development
• 11.5 HRA Pharma
  • 11.5.1 HRA Pharma Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 HRA Pharma Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 HRA Pharma Intrauterine Devices Products Offered
  • 11.5.5 HRA Pharma Recent Development
• 11.6 Eurogine
  • 11.6.1 Eurogine Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Eurogine Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Eurogine Intrauterine Devices Products Offered
  • 11.6.5 Eurogine Recent Development
• 11.7 Yantai JiShengYaoXie
  • 11.7.1 Yantai JiShengYaoXie Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Yantai JiShengYaoXie Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Yantai JiShengYaoXie Intrauterine Devices Products Offered
  • 11.7.5 Yantai JiShengYaoXie Recent Development
• 11.8 TianYi
  • 11.8.1 TianYi Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 TianYi Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 TianYi Intrauterine Devices Products Offered
  • 11.8.5 TianYi Recent Development
• 11.9 SMB Corporation
  • 11.9.1 SMB Corporation Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 SMB Corporation Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 SMB Corporation Intrauterine Devices Products Offered
  • 11.9.5 SMB Corporation Recent Development
• 11.10 Shenyang Liren
  • 11.10.1 Shenyang Liren Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Shenyang Liren Intrauterine Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Shenyang Liren Intrauterine Devices Products Offered
  • 11.10.5 Shenyang Liren Recent Development
• 11.11 H & J Medical

12 Future Forecast

• 12.1 Intrauterine Devices Market Forecast by Regions
  • 12.1.1 Global Intrauterine Devices Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Intrauterine Devices Revenue Forecast by Regions 2019-2025
• 12.2 Intrauterine Devices Market Forecast by Product
  • 12.2.1 Global Intrauterine Devices Sales Forecast by Product 2019-2025
  • 12.2.2 Global Intrauterine Devices Revenue Forecast by Product 2019-2025
• 12.3 Intrauterine Devices Market Forecast by End User
• 12.4 North America Intrauterine Devices Forecast
• 12.5 Europe Intrauterine Devices Forecast
• 12.6 Asia Pacific Intrauterine Devices Forecast
• 12.7 Central & South America Intrauterine Devices Forecast
• 12.8 Middle East and Africa Intrauterine Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Intrauterine Devices Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Intrauterine devices (IUDs) are contraceptive medical implants used to prevent pregnancies for a long period of time. They are also known as long-acting reversible contraceptive devices.
China is the largest consumption place, with a consumption market share nearly 53% in 2016. Following Europe, Europe is the second largest consumption place with the consumption market share of 16%.
Market competition is not intense. Bayer, Merck, Teva Pharmaceutical, Allergan, etc. are the leaders of the industry, and they hold key technologies and market, with high-end customers; have been formed in the large market share in the industry.
The global Intrauterine Devices market is valued at 2910 million US$ in 2018 and will reach 3460 million US$ by the end of 2025, growing at a CAGR of 2.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Intrauterine Devices market based on company, product type, end user and key regions.

This report studies the global market size of Intrauterine Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intrauterine Devices in these regions.
This research report categorizes the global Intrauterine Devices market by top players/brands, region, type and end user. This report also studies the global Intrauterine Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
Merck
Teva Pharmaceutical
Allergan
HRA Pharma
Eurogine
Yantai JiShengYaoXie
TianYi
SMB Corporation
Shenyang Liren
H & J Medical

Market size by Product
Hormonal IUD
Copper IUD
Market size by End User
Age 20-24
Age 25-34
Age 35-44
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Intrauterine Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Intrauterine Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Intrauterine Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Intrauterine Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Intrauterine Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Intrauterine Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.